CCL2 directly stimulates prostate cancer cell proliferation and migration via activation of the phosphatidylinositol 3-kinase (PI3K)/ protein kinase B (Akt) signaling pathway and Rac GTPase, respectively [13]. This evidence concerns the gene AKT1 and prostate carcinoma.